2026-11-12 03:00
Miro clears TGA audit ahead of Crohn’s disease trial
Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.
https://www.theage.com.au/business/companies/miro-clears-tga-audit-ahead-of-crohn-s-disease-trial-20261112-p61dlz.html?ref=rss&utm_medium=rss&utm_source=rss_feed
#theage
https://www.theage.com.au/business/companies/miro-clears-tga-audit-ahead-of-crohn-s-disease-trial-20261112-p61dlz.html?ref=rss&utm_medium=rss&utm_source=rss_feed
#theage